Rigel Pharmaceuticals, Inc. (RIGL)
29.97
+0.77
(+2.64%)
USD |
NASDAQ |
Apr 13, 16:00
29.97
0.00 (0.00%)
After-Hours: 05:06
Rigel Pharmaceuticals Cash from Investing (TTM) : -92.36M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Eli Lilly & Co. | -10.97B |
| BioMarin Pharmaceutical, Inc. | -414.24M |
| Amicus Therapeutics, Inc. | -46.43M |
| Nektar Therapeutics | -1.197M |
| Madrigal Pharmaceuticals, Inc. | 32.32M |